Skip to main content
. 2021 Jun 15;105(2):368–371. doi: 10.4269/ajtmh.20-1657

Table 2.

Candidate variables affecting the association of SCT with COVID-19 positivity and mortality in Black individuals of the UK Biobank

Variables SCT carriers SCT carriers with COVID-19
COVID-19-positive (N = 14) COVID-19- negative (N = 57) OR (95% CI) P value Died of COVID-19 (N = 4) Remained alive (N = 10) OR (95% CI) P value
Demographic factors
Age, mean (SD) 64.37 (8.05) 64.26 (8.66) 1 (0.93–1.07) 0.97 73.86 (4.66) 60.57 (5.5) 1.98 (1.11–11.62) 0.009
Sex, no. of females 8 (57.1%) 46 (80.7%) 0.32 (0.08–1.38) 0.08 4 (100%) 4 (40%) 0.17 (0–1.66) 0.08
Smoking, current/ previous 2 (14.3%) 18 (31.6%) 0.36 (0.04–1.87) 0.32 1 (25%) 1 (10%) 2.68 (0.03–238.74) 0.50
BMI, mean (SD) 30.09 (4.85) 29.99 (4.8) 1 (0.88–1.14) 0.94 32.4 (3.34) 29.06 (5.22) 1.15 (0.89–1.56) 0.33
Genetic factors
APOE, ε4-positive, n 3 (21.4%) 19 (33.3%) 0.62 (0.10–2.88) 0.74 2 (50%) 1 (10%) 9.84 (0.35–770.19) 0.12
ABO, type O, n 7 (50%) 28 (49.1%) 1.04 (0.31–3.52) > 0.99 1 (25%) 6 (60%) 0.37 (0.00–9.28) 0.57
Comorbidity
Diabetes, n 4 (28.6%) 7 (12.3%) 2.81 (0.51–13.80) 0.21 4 (100%) 0 (0%) 90.71 (5.66–inf) 4.70E-04
Obesity (BMI ≥ 30), n 6 (42.9%) 28 (49.1%) 0.86 (0.26–2.87) > 0.99 3 (75%) 3 (30%) 4.94 (0.29–312.26) 0.26
Chronic obstructive pulmonary disease, n 2 (14.3%) 9 (15.8%) 0.89 (0.08–5.19) > 0.99 0 (0%) 2 (20%) 1.04 (0–14.58) > 0.99
Hypertension, n 10 (71.4%) 32 (56.1%) 1.94 (0.48–9.48) 0.37 4 (100%) 6 (60%) 2.95 (0.28–inf) 0.24
Cancer diagnosis, n 0 (0%) 8 (14%) 0 (0.00–2.36) 0.34 0 (0%) 0 (0%)
Stroke, n 0 (0%) 1 (1.8%) 0 (0.00–158.40) > 0.99 0 (0%) 0 (0%)

APOE = apolipoprotein E; BMI = body mass index; CI = confidence interval; inf = infinite; OR = odds ratio; SCT = sickle cell trait; SD = standard deviation. The analysis of variance test was used for continuous variables. Fisher’s exact test was used when the expected number of subjects in any cell was < 5.